MedPath

Training in the 21st Century: Using Virtual Role-Plays to Improve Nurse Communication for Medication Adherence

Not Applicable
Completed
Conditions
Hypertension
High Blood Pressure
Registration Number
NCT03599050
Lead Sponsor
NYU Langone Health
Brief Summary

This study will utilize a three-phase approach that is informed by a theory-driven implementation framework to: 1) conduct a needs analysis in order to identify individual-, health care team-, and practice-level barriers and facilitators to conducting adherence counseling in safety-net primary care practices; 2) develop a virtual communication simulation designed to improve the quality of adherence counseling by allowing nurses repeated opportunities to practice discussing medication adherence with virtual patients; and 3) conduct a pilot study to evaluate the feasibility, acceptability and preliminary efficacy of the simulation on changes in: a) nurses' collaborative communication skills, b) medication adherence, and c) reduction in BP in a sample of 20 patients with uncontrolled hypertension (HTN) who are non-adherent to their medications.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • PCPs and nurses will be enrolled if they fulfill the following criteria:

    1. male or female healthcare provider (MD/DO, NP, and Registered Nurse) practicing at the clinic
    2. age 18 years or older.

No exclusions will be made based on provider race/ethnic origin. We will oversample males to examine differential communication skills based on gender.

  • Patient eligibility criteria include:

    1. receiving care at the participating clinic
    2. having uncontrolled HTN (BP>140/90 mmHg) at two visits in the past year
    3. being prescribed at least one antihypertensive medication and are non-adherent
    4. are ≥age 18 years
    5. fluent in English
Exclusion Criteria
  • Unable to give consent
  • Have a diagnosis of cognitive dysfunction or significant psychiatric comorbidity,
  • Participating in another HTN-related study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Feasibility measured by documenting total available and eligible nurses and patients approached to enroll 1 participant through final study visit6 Months
Acceptability measured by % of nurses who complete the simulation6 Months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NYU School of Medicine

🇺🇸

New York, New York, United States

NYU School of Medicine
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.